Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece
- PMID: 35979460
- PMCID: PMC9376377
- DOI: 10.3389/fpubh.2022.921243
Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece
Erratum in
-
Erratum: Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece.Front Public Health. 2022 Nov 10;10:1034544. doi: 10.3389/fpubh.2022.1034544. eCollection 2022. Front Public Health. 2022. PMID: 36438227 Free PMC article.
-
Erratum: Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece.Front Public Health. 2023 Jan 13;10:1114452. doi: 10.3389/fpubh.2022.1114452. eCollection 2022. Front Public Health. 2023. PMID: 36711371 Free PMC article.
Abstract
Background: Increased morbidity/mortality due to vaccine preventable diseases (VPD) is encountered in type 2 diabetes (T2D) people. Aim of this study was to assess their vaccination coverage and describe trends possibly affecting compliance.
Methods: Information on vaccination coverage was retrieved from either documents or interview provided by patients, and/or their vaccination record card at a specialized outpatient diabetes center. The selection of the patients was arbitrary.
Results: An increasing vaccination rate for influenza was observed from 2018 to 2020 among 372 participants. The vaccination coverage for S.pneumoniae was 67.2% (PCV13), 20.4% (PPSV23), 26.3% for herpes zoster in individuals ≥60 years, 1.9% for tetanus-diphtheria-pertussis and 1.1% for hepatitis B. A 10.2% of participants were found to be unvaccinated. Vaccination uptake for influenza and PCV13 was related to age, ≥3 comorbidities and long-term follow-up. T2D individuals consecutively vaccinated for influenza were 3.78 times more likely to be also vaccinated with PCV13.
Conclusions: Vaccination rates of patients with T2D show an increasing trend, especially for influenza and S. pneumoniae, although the one for S. pneumoniae was low. Older people seem more prone to vaccination, the one for herpes zoster was low with infected patients remaining unvaccinated while significantly low coverage was observed for other VPDs. The findings are important to improve effectiveness of preventative services.
Keywords: infections; prevention; primary care; type 2 diabetes; vaccination.
Copyright © 2022 Galanos, Dimitriou, Pappas, Perdikogianni, Symvoulakis, Galanakis and Lionis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- International Diabetes Foundation ATLAS 9th Edition 2019–Global Factsheet. (2019). Available online at: https://www.diabetesatlas.org/en/
-
- Verma VK, Ram VS, Singh PS, Kumar M, Awasthi S, Kela D. Herpes zoster as a presentation of diabetes mellitus. Int J Res Med Sci. (2017) 5:1878–81. 10.18203/2320-6012.ijrms20171810 - DOI
-
- National Vaccination Program of Adults 2018-2019 – Ministry of Health. Available online at: https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/embo... (accessed September 5, 2018).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
